These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24194477)

  • 1. Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis.
    Eil R; Diggs BS; Wang SJ; Dolan JP; Hunter JG; Thomas CR
    Cancer; 2014 Feb; 120(4):492-8. PubMed ID: 24194477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
    Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
    Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
    Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
    Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT
    Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
    Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
    Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer.
    Stiles BM; Christos P; Port JL; Lee PC; Paul S; Saunders J; Altorki NK
    J Thorac Cardiovasc Surg; 2010 Feb; 139(2):387-94. PubMed ID: 20006355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
    Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
    Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
    Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
    J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients.
    Gaur P; Sepesi B; Hofstetter WL; Correa AM; Bhutani MS; Vaporciyan AA; Watson TJ; Swisher SG;
    Ann Surg; 2010 Oct; 252(4):611-7. PubMed ID: 20881767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node identification following neoadjuvant therapy in rectal cancer: A stage-stratified analysis using the surveillance, epidemiology, and end results (SEER)-medicare database.
    Ecker BL; Paulson EC; Datta J; Jeganathan AN; Aarons C; Kelz RR; Mahmoud NN
    J Surg Oncol; 2015 Sep; 112(4):415-20. PubMed ID: 26250884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database.
    Groth SS; Virnig BA; Whitson BA; DeFor TE; Li ZZ; Tuttle TM; Maddaus MA
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):612-20. PubMed ID: 19709685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma.
    Yendamuri S; Huang M; Malhotra U; Warren GW; Bogner PN; Nwogu CE; Groman A; Demmy TL
    Cancer; 2013 Sep; 119(17):3156-61. PubMed ID: 23719932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.
    Ho HJ; Chen HS; Hung WH; Hsu PK; Wu SC; Chen HC; Wang BY
    Ann Surg Oncol; 2018 Dec; 25(13):3820-3832. PubMed ID: 30284131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals.
    Merkow RP; Bilimoria KY; McCarter MD; Chow WB; Ko CY; Bentrem DJ
    Ann Surg Oncol; 2012 Feb; 19(2):357-64. PubMed ID: 21769460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
    Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
    Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction.
    Lagarde SM; Reitsma JB; Ten Kate FJ; Busch OR; Obertop H; Zwinderman AH; Moons J; van Lanschot JJ; Lerut T
    Ann Surg; 2008 Dec; 248(6):1006-13. PubMed ID: 19092345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.